Efficacy of Breast Milk in Healing of Skin Damage
1 other identifier
interventional
36
1 country
1
Brief Summary
The population of the research will be preterm infants born 35-36 weeks of gestation, hospitalized in the Neonatal Intensive Care Unit of Karaman State Hospital, whose skin is damaged due to Intravenous (IV) vascular access fixation bands, and whose skin has not been subjected to any other application before. Calculation of the sample number of the research; It was determined that at least 24 newborns should be assigned to each group (α = 0.05 and β = 0.19) to show that the 1 degree difference between the cream group and the breast milk group was significant for 80.7% strength. It is planned to take a premature baby. As data collection tools, Premature Babies Descriptive Information Form, Newborn Skin Condition Assessment Scale, Medical Adhesives and Solvents Used in the Neonatal Intensive Care Unit, Human Milk and routine care will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedMarch 28, 2023
March 1, 2023
26 days
May 11, 2022
March 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
skin damage
The change in skin damage after the intervention with newborn skin condition assessment scalewill be monitored.
3 weeks
Study Arms (2)
humanmilk
EXPERIMENTALFor skin damage care of preterm newborns randomly assigned to the breast milk group, their own breast milk will be applied topically once every 60 minutes until complete healing. Skin damage in newborns will be evaluated by an independent nurse and specialist doctor for 60 minutes during the treatment, and the score will be given and recorded. A minimum decrease of 1 point in the skin condition assessment scale score will be considered to indicate 'improvement'. The decision that the skin integrity of the newborn is completely healed will be made by the neonatal doctor independent of the trial. Areas between 0-3 on the newborn skin condition assessment scale will be considered healed. Breastfeeding does not have any side effects in preterm newborns.
routine care group
EXPERIMENTALcream applied as part of hospital routine practice
Interventions
For skin damage care of preterm newborns randomly assigned to the breast milk group, their own breast milk will be applied topically once every 60 minutes until complete healing. Skin damage in newborns will be evaluated by an independent nurse and specialist doctor for 60 minutes during the treatment, and the score will be given and recorded. A minimum decrease of 1 point in the skin condition assessment scale score will be considered to indicate 'improvement'. The decision that the skin integrity of the newborn is completely healed will be made by the neonatal doctor independent of the trial. Areas between 0-3 on the newborn skin condition assessment scale will be considered healed. Breastfeeding does not have any side effects in preterm newborns.
Eligibility Criteria
You may qualify if:
- Written and verbal consent of the parents,
- The newborn is less than 37 weeks of gestation,
- Being in the Neonatal Intensive Care Unit,
- The intravenous catheter has been fixed to the skin with a silk patch,
- For intravenous catheter fixation, the bands remain on the skin for a minimum of 24 hours and a maximum of 32 hours,
- While removing the adhesive tape, remove it slowly and carefully by softening the tape with cotton moistened with water,
- The parent speaks and understands Turkish comfortably,
- Stable health status
- Having spontaneous breathing
- Not being exposed to a painful procedure at least half an hour before the interventions.
- Not taking opioid or non-opioid analgesics
- Not receiving any antibiotic treatment,
- Having breast milk
You may not qualify if:
- Parent's inability to speak and understand Turkish easily,
- Parents do not give written and verbal consent,
- Intravenous catheter not fixed to the skin with a silk patch,
- For intravenous catheter fixation, the bands should not remain on the skin for a minimum of 24 hours and a maximum of 32 hours,
- Removal of the intravenous catheter from the skin using a solvent solution,
- Having ventilator support
- Presence of congenital anomaly
- Using analgesic / narcotic analgesic drugs
- Receiving any antibiotic treatment,
- Continuous sedative treatment
- Discontinuation of topical breast milk or cream application procedure for any reason
- Parent's wish to leave the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ayşe Sonay Türkmen
Karaman, 70100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr
Study Record Dates
First Submitted
May 11, 2022
First Posted
May 25, 2022
Study Start
August 1, 2022
Primary Completion
August 27, 2022
Study Completion
November 1, 2022
Last Updated
March 28, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share